Monthly chart | M | EMA 5 8 13 | Uptrend | Gap above EMA 5 | String upper trend
W chart | W time frame |
D chart | D time frame |
Monday, October 28, 2024
Sunday, October 27, 2024
PYPL stock | M | W | D | Chart | Long term investing
Monthly chart | Pypl | What we can tell
PYPL stock will go up and then go above EMA13 again, last time the price above EMA13 is in 2021.
Right now the price went up close to 2022 first quarter.
Weekly chart
Daily chart
Sept 12 2024 | EMA 5 8 13 | close together | Long area | Slow down uptrend in a few days
Saturday, October 26, 2024
Friday, October 25, 2024
American Airlines Analysts Boost Their Forecasts After Better-Than-Expected Earnings
by
American Airlines Group Inc.
The airline reported third-quarter total operating revenue growth of 1.2% year-over-year to $13.647 billion, beating the consensus of $13.471 billion. The adjusted operating margin stood at 4.7% compared to 5.4% a year ago. AAL reported adjusted EPS of 30 cents, down from 38 cents a year ago but above the consensus of 15 cents.
For 2024, American Airlines now expects an adjusted EPS of $1.35 – $1.60 (prior $0.70 – $1.30) versus the consensus of $1.21. It expects a 2024 operating margin of 4.5% to 5.5%
AAL shares gained 2.2% to trade at $13.06 on Friday.
These analysts made changes to their price targets on AAL following earnings announcement.
- JP Morgan analyst Jamie Baker maintained American Airlines with an Overweight and raised the price target from $15 to $20.
- B of A Securities analyst Andrew Didora maintained American Airlines with an Underperform and raised the price target from $9 to $10.
- TD Cowen analyst Thomas Fitzgerald maintained American Airlines with a Hold and raised the price target from $9 to $10.
Considering buying AAL stock? Here’s what analysts think:
About Anne-Marie Baiynd | https://thetradingbook.com/
About Anne-Marie Baiynd
Twenty year market veteran guiding traders
Anne-Marie Baiynd has been trading for over twenty years and
is featured often in major fintech outlets and aligned with several trading
platforms. She appears frequently on Benzinga Pro, Edgeful, Investors Business
Daily, Metastock, MenthorQPro, MotiveWave, Trendspider, TopstepTV, and
Traderade.
IBD digital | IBD Live: Friday, Oct. 25
IBD Live: Friday, Oct. 25
#IBDLive #IBDLiveCoaching #Coaching #90minutes
1:48:12
IBD’s team of writers, analysts and portfolio managers
breaks down the first 90 minutes of market action and discusses their top trade
ideas.
The following link has been updated to reflect today's edited Q&A and two key stock lists.
Please check out our FAQ page. It can help you with all aspects of successful
growth stock investing. In the "Weekly Industry Group Analysis"
section of the FAQ page you can view a spreadsheet of the latest industry
groups analysis. The latest update runs as of the week ended Oct. 18.
The show began with an assessment of trading conditions.
Anne-Marie Baiynd, president of The Trading Book, futures trader and a weekly
options columnist on Investors.com, returned to the show. Anne-Marie discussed
her feel of the current market indexes and offered a variety of options strategies for stocks ranging from Intuitive
Surgical (ISRG) and Skechers (SKX) to Capri (CPRI) and Tesla (TSLA). Mike Webster shed light on the high, tight flag "in spirit" with Astera
Labs (ALAB). Chris Gessel noted the strong 10-week line support
for On (ONON).
Other stocks and ETFs featured on today's show included
TSLA, GS, ONON, ALAB, SPY, QQQ, DIA, zero-TNX, DECK, SKX, ENSG, TXRH, RMD, LHX,
FIX, APPF, OKLO, CPRI, TPR, SG, CAVA, CLS, VITL, PKG, VKTX, ISRG, LUNR, CPNG,
NNE, RSP and more.
Thursday, October 24, 2024
Gamble on ASTS, MSTR?
Why do you buy these stocks ASTS - MSTR which have terrible fundamentals even though the charts may look OK ? Why speculate on them when there are others with better fundamentals ?
I'm with you. I want to see strong fundamentals.
AAL stock | Earnings | Oct 24 2024
American Airlines Reports $149 Million Loss as Business-Travel Reboot Continues
American Airlines said moves to reset its business-travel strategy were progressing, as it reported a $149 million quarterly net loss.
The airline said it renegotiated contracts with many top corporate customers as it works to win back business, while increasing sales staff and reintroducing benefits for corporate travelers.
American has backed away from an earlier bet that it could coax more travelers to book directly on its website and app. The airline had slashed its sales staff and removed some fares from the channels big companies tend to use.
American on Thursday projected full-year adjusted earnings of between $1.35 and $1.60 a share, up from a range of $0.70 and $1.30 forecast in the prior quarter.
American stock rose in Thursday morning trading.
The carrier in July slashed its annual earnings outlook and said it expected to break even in the third quarter as it contended with an overhang of airline seats that pressured U.S. fares. Rivals including United Airlines and Delta Air Lines have said the glut is easing as carriers—especially discounters—cut back, helping boost ticket prices this fall.
Other highlights from American’s report:
American’s loss narrowed, compared to a $545 million quarterly loss a year earlier.
Third-quarter revenue hit a record $13.65 billion, up 1.2% from a year earlier and above analysts’ projections of $13.5 billion.
Adjusting for one-time items, quarterly earnings totaled 30 cents a share, above the 16 cents projected by analysts.
Wednesday, October 23, 2024
IBD digital | The 21-Day Exponential Moving Average: Why This Is Your New Edge
Here is the article.
VRT was down 7.5% ten minutes ago but opened down 5.3%. That kept it above the 21-day at the open.
Right. For the leaders, we def like to see that, right Ira? https://www.investors.com/how-to-invest/investors-corner/what-is-the-21-day-exponential-moving-average/
The 21-day exponential moving average (EMA) can be thought of as the Goldilocks of moving averages.
We have dozens of Investor's Corners on when to buy a stock and when to sell. But what about holding?
A 10-day simple moving average (SMA) can be too tight and a 50-day simple moving average too loose.
If you accumulate enough experience in the CAN SLIM investing strategy, you might often conclude that the 21-day EMA can often be just right.
The Sitting Is The Hardest Part
Buying a stock is typically fun and straightforward.
Selling is often scary. Even after a big gain, you may wonder, "Did I sell too early or too late?" Holding your winning stock until a close below the 21-day line can help to reduce that stress. The negative? You will never sell at the top. The positive? You will dramatically reduce the shakeouts.
In an exponential moving average, the most recent price action carries a higher weighting.
How To Invest: A 135% Profit In Sea With The 21-Day EMA
Sea Limited (SE), a global platform for video games, is a great example of how using the 21-day EMA can help you capitalize on a huge move.
Sea Limited broke out of a short cup-without-handle base with a 52.87 buy point on April 16, 2020 (1), closing at 53.95.
It immediately paused, creating a small upward-slanting shelf pattern. The stock broke above this on May 5 (2).
On May 26, it gapped to new highs. The question is this: Sell into strength or to hold on for a bigger move? Utilizing this rule of holding a winner until it closes below the 21-day line would have helped you sit tight the following day when it closed down 5.1% on heavy volume.
As of July 8, 2020, it was still above the 21-day exponential moving average, marking a new closing high at 124.46. That's a 135% gain without thinking.
Sea Limited finally got flooded with sellers — in the near term — during a three-day sell-off that sent shares plunging as much as 12%. For two days straight, shares closed below the 21-day line.
However, the stock bounced sharply off its July 24 low. Plus, it refused to cave below its 50-day moving average. At this point, the profit cushion was still thick.
As Jesse Livermore, the subject of Edwin Lefevre's stock market classic "Reminiscences of a Stock Operator," once remarked, "It never was my thinking that made the big money for me. It was always my sitting. Got that? My sitting tight!"
21-Day Exponential Moving Average For Indexes?
Not only does the 21-day work for individual stocks, it works great for indexes, too.
IBD Charts do not include the 21-day line. On Leaderboard charts, the 21-day line in drawn in green. Subscribers to MarketSmith can set up custom moving averages.
A version of this story was first published in July 2020. Please follow Webster on X at @mwebster1971 and Chung at @SaitoChung and @IBD_DChung for more on growth stocks, chart analysis, bases, breakouts and sell signals.
MarketBeat | Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy
Here is the article.
Key Points
- Walgreens Boots Alliance's metrics are improving as the company reported a 6% growth in YoY revenue, beating consensus EPS by 3 cents.
- Walgreens’ current assets are worth twice its current market capitalization.
- Walgreens trades at just 3.9x forward earnings and pays the highest dividend in the S&P 500% at 9.27%.
- 5 stocks we like better than Walgreens Boots Alliance.
Walgreens Boots Alliance Inc. NASDAQ: WBA is a leading global retail pharmacy and healthcare company. The stock is trading down 60% from its 52-week high and with a stock performance down 58.5% year-to-date (YTD). The market has punished this stock and its (remaining) top competitor, CVS Health Co. NYSE: CVS, in the retail/wholesale sector. Competition from all fronts, including online pharmacies like Amazon.com Inc. NASDAQ: AMZN to department stores with pharmacies and household products like Walmart Inc. NYSE: WMT and Target Co. NYSE: TGT, have eroded Walgreens's market share. Yet, its third quarter of 2024 earnings release is fueling positive sentiment in the stock as the company tries to climb its way back. Here are four reasons to consider buying the stock now.
1) The Turnaround Is Taking Shape as Growth Metrics Improve
Unlike CVS Health, which had a 9% year-over-year (YoY) revenue decline in its recent quarter, Walgreens saw its revenue grow 6% YoY to $37.5 billion, beating consensus estimates by $200 million in its fiscal fourth quarter of 2024. The company earned 39 cents per share, beating consensus estimates by 3 cents. Also, unlike CVS Health, which is also a payor through its Aetna health insurance subsidiary, Walgreens's healthcare segment operates as providers. This has shielded them from the growing medical benefits ratio (MBR) that insurers are seeing cutting into their margins, notably with their Medicare Advantage members.
Walgreens Pharmacy sales rose 9.6% YoY, with strong comparable (comp) pharmacy sales up 11% YoY. However, Retail sales dropped 3.5% YoY as comps fell 1.7% YoY. Its VillageMD revenues rose 7.2% YoY as fee-for-service revenues rose. Its Shields revenue rose 27.8% YoY, driven by growth within existing partnerships. Walgreens exceeded its target of $1 billion in cost savings in fiscal 2024.
Walgreens is also planning to trim costs by shuddering 1,200 underperforming stores over the next three years, starting with 500 in fiscal 2025. This is expected to boost free cash flow and adjusted EPS immediately.
2) Its Assets Are Worth More Than Its Market Capitalization
Walgreens's 10-K lists its current assets at $18.34 billion, which is twice its current market capitalization (cap) of $9.33 billion. Its property, plant, and equipment, valued at $9.8 billion, exceeds its current market cap. Of course, they still have total short-term and long-term debt combined, totaling $32.67 billion, which is significant. However, the interest rate cut cycle should improve its financing costs.
Approximately 78% of the U.S. population live within five miles of a Walgreens or Duane Reade, which provides convenient proximity for its healthcare services. Walgreens Find Care is a telehealth platform that connects patients and customers with healthcare options from the mobile app. The company operates over 13,000 stores worldwide, including 3,688 retail Boots stores and optician locations in the United Kingdom. Walgreens is still a major shareholder of drug and healthcare products distributor Cencora Inc. NYSE: COR, formerly AmerisourceBergen, which it still owns 10% of, valued at around $4 billion.
3) Its Valuation Is Historically Cheap, With Prices Not Seen Since 1997
WBA stock is trading at historically cheap levels at just 3.79x forward earnings (forward P/E). Its Price-to-book (P/B) ratio is 0.33. Its price-to-cash flow is 1.37. Its price-to-sales (P/S) is 0.06. Even at $10.79 per share, it's trading at levels not seen since 1998.
WBA is the highest-paying dividend stock in the S&P 500, with a 9.25% annual dividend yield. It's also a potential reality of WBA being removed from the S&P 500 index after being replaced by Amazon in the Dow Jones Industrial Average (DJIA) on Feb. 26, 2024.
While the stock is up 15.4% year-to-date (YTD), it may get a Santa Clause rally and a January Effect rally from end-of-year tax loss selling from long-term shareholders portfolio balancing or just throwing in the towel.
4) WBA Stock Is Forming a Cup and Handle Pattern
A cup pattern is completed when the stock falls from a swing-high cup lip line to a low one, forms a rounding bottom and rallies back to retest the cup lip line. The handle forms when the stock pulls back from the cup lip line, surges back up, and remains above the cup lip line, which becomes a price support level.
WBA formed the cup lip line at $11.14 as shares fell to a low of $8.25, forming a rounding bottom that staged a rally back to the $11.14 lip line test. WBA shares are in a pullback, which can form the handle when it reverses and trigger the cup and handle breakout if it can surge through and remain above the $11.14 lip line. The daily anchored VWAP support is rising at $9.52. The daily RSI rose to the 62-band. Fibonacci (Fib) pullback support levels are at $10.72, $10.19, $8.93, and $8.25.
Walgreens Boots Alliance’s average consensus price target is $13.38, and its highest analyst price target sits at $22.00. It has two analysts' Buy ratings, eight Hold, and four Sell ratings. The stock has a 13.3% short interest.
Actionable Options Strategies: Bullish investors can consider using cash-secured puts to buy WBA at the Fib pullback support levels for entry and write covered calls to execute a wheel strategy for income in addition to the 9.27% annual dividend yield.
CI | Cigna | Cigna group
The Cigna Group is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut.[2][3] Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g., governmental and non-governmental organizations, unions and associations). Cigna is incorporated in Delaware.[4]
The company ranked #15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue[5] and in the 2023 Forbes Global 2000 ranking the company took 68th place.[6]
Subscribe to:
Posts (Atom)